0      0

65458 - Session III: Control Strategies

‐ May 11, 2023 12:20pm


Vanessa Wong, AstraZeneca

Development of an Analytical Toolbox for the Detection, Confirmation, and Characterisation of Partially Reduced Species in Monoclonal Antibodies

Lars Geurink, Janssen Vaccines & Prevention B.V.

AQbD Method Control Strategy

Bastiaan Duivelshof, University of Geneva

How to Use Protein Specific Retention Behaviour to Improve the Characterization of Therapeutic Antibodies

You must be logged in and own this session in order to post comments.